Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment–specific patient-reported outcome measure

OBJECTIVES: Glucocorticoids (GCs) (‘steroids’) are used to treat rheumatic diseases but adverse effects are common. We aimed to explore the impact of GC therapy on health-related quality of life (HRQoL), to inform the development of a treatment-specific patient-reported outcome measure (PROM) for us...

Descripción completa

Detalles Bibliográficos
Autores principales: Bridgewater, Susan, Shepherd, Michael A, Dawson, Jill, Richards, Pamela, Silverthorne, Christine, Ndosi, Mwidimi, Almeida, Celia, Black, Rachel J, Cheah, Jonathan T L, Dures, Emma, Ghosh, Nilasha, Hoon, Elizabeth A, Lyne, Suellen, Navarro-Millan, Iris, Pearce-Fisher, Diyu, Ruediger, Carlee, Tieu, Joanna, Yip, Kevin, Mackie, Sarah L, Goodman, Susan, Hill, Catherine, Robson, Joanna C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629780/
https://www.ncbi.nlm.nih.gov/pubmed/36840642
http://dx.doi.org/10.1093/rheumatology/kead081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629780/
https://www.ncbi.nlm.nih.gov/pubmed/36840642
http://dx.doi.org/10.1093/rheumatology/kead081

Ejemplares similares